This year marks the 40th anniversary of in vitro fertilization (IVF). This conference brings together an internationally-renowned faculty to present the latest developments in every phase of IVF and embryo management. The course addresses the needs of practicing scientists, gynecologists, reproductive endocrinologists, residents, and fellows who wish to review the specialty and update their knowledge in this rapidly changing and expanding field.

The conference setting promotes extensive contact among speakers and participants with question periods, panels, and many opportunities for informal interaction. A mobile app will be utilized to access the material being presented, and electronic polling through the mobile app will be used to promote interaction with the speakers.

Particular attention will be devoted this year to the rapidly developing trend toward deferred embryo transfer, the role of mild ovarian stimulation, time lapse imaging of early embryo development, the critical role of embryo energy supplies, the measurement of mitochondrial DNA to assess embryo capacity, genetic evaluation of the infertile couple and early pregnancy, management of mosaic embryos, the role of CoQ10 in improving mitochondrial function in aging women, maternal immunogenetics, and practical aspects of transfer technique. There will be a lively debate on whether PGS is indispensable or too inaccurate for clinical use. A laboratory mini-symposium directed by Dr. William B. Schoolcraft will cover comprehensive chromosome screening challenges, newer techniques to assess endometrial receptivity, time-lapse assessment of embryos versus routine blastocyst culture, molecular assessments of sperm, oocyte freezing, and a diagnostic role for RNAs.

Shoukhrat Mitalipov, PhD from the OHSU Center for Embryonic Cell and Gene Therapy will give the keynote lecture on the recent breakthrough reported last year in Nature on gene editing of human embryos. He will also update us on the use of stem cells as a source of oocytes and sperm.

Target Audience

The target audience for this initiative includes physicians, fellows, physician assistants, nurse practitioners, embryologists and other allied health professionals in the field of IVF.

Objectives

At the completion of the course, participants should be able to:

  • Describe standard, successful methods of each aspect of the clinical practice of assisted reproductive technology and in particular the very significant advantages of deferred embryo transfer, made possible through vitrification; alternatives to full stimulation; prevention of OHSS; the role of lifestyle issues in the male and female; time-lapse monitoring of embryos; aging of the oocyte; techniques for comprehensive chromosome screening; optimal hormone replacement for embryo transfer; and critical aspects of embryo transfer technique.
  • Discuss aspects of embryo culture and embryo management to achieve optimal results with IVF.
  • Identify current techniques and challenges with comprehensive chromosome screening, options for fertility preservation for the woman with cancer, and immunologic aspects of implantation.

UCSD CMEUCSD CME facebook UCSD CME twitter

Content is subject to change without notice. Please refer to the activity website for the most current information.

Official website of the University of California, San Diego. Copyright ©2018 Regents of the University of California. All rights reserved.